KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Raw Materials (2016 - 2018)

Idexx Laboratories has reported Raw Materials over the past 9 years, most recently at $35.0 million for Q1 2018.

  • For Q1 2018, Raw Materials rose 23.82% year-over-year to $35.0 million; the TTM value through Mar 2018 reached $35.0 million, up 23.82%, while the annual FY2017 figure was $33.0 million, 19.71% up from the prior year.
  • Raw Materials for Q1 2018 was $35.0 million at Idexx Laboratories, up from $33.0 million in the prior quarter.
  • Over five years, Raw Materials peaked at $35.0 million in Q1 2018 and troughed at $23.5 million in Q1 2014.
  • A 5-year average of $29.6 million and a median of $30.3 million in 2016 define the central range for Raw Materials.
  • Biggest five-year swings in Raw Materials: increased 24.32% in 2015 and later dropped 11.85% in 2017.
  • Year by year, Raw Materials stood at $26.9 million in 2014, then increased by 15.89% to $31.2 million in 2015, then decreased by 11.62% to $27.6 million in 2016, then rose by 19.71% to $33.0 million in 2017, then rose by 5.95% to $35.0 million in 2018.
  • Business Quant data shows Raw Materials for IDXX at $35.0 million in Q1 2018, $33.0 million in Q4 2017, and $32.3 million in Q3 2017.